Health ❯ Healthcare ❯ Chronic Diseases

Diabetes Management

Liraglutide Weight Loss Solutions Therapeutic Innovations Patient Care GLP-1 Agonists Type 2 Diabetes Antidiabetic Medications Blood Sugar Control AI in Diagnostics Treatment Options GLP-1 Receptor Agonists Medication Risks Metabolic Surgery Innovative Treatments Insulin Administration Cardiovascular Risk Factors

7 ARTICLES

4mo ago

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

The authorization adds a needle-free, ultra‑rapid mealtime insulin for young patients with required lung‑function checks and a company affordability program.